Trial Details
TERMINATEDBasic Information
| Clinical ID | c2850 |
|---|---|
| Identifier | NCT02878083 |
| Trial Title | Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | ULCERATIVE COLITIS |
| Interventions | DRUG: VEDOLIZUMAB|DRUG: ADALIMUMAB |
Participant Information
| Sponsor | Nantes University Hospital |
|---|---|
| City | Angers |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2017-01-11 |
|---|---|
| Primary Completion Date | 2020-01 |
| Completion Date | 2021-01-01 |